Lipigon Pharmaceuticals AB's total assets for Q3 2024 were kr21.03M, a decrease of -30.62% from the previous quarter. DE:9RP total liabilities were kr2.56M for the fiscal quarter, a -49.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.